Agilon Health (AGL) Depreciation & Amortization (CF) (2020 - 2026)

Agilon Health (AGL) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $6.8 million in Q1 2026.

• Quarterly Depreciation & Amortization (CF) fell 1.29% year-over-year to $6.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $28.5 million (up 11.81% YoY) and the FY2025 annual result came in at $28.6 million, up 16.89% from the prior year.
• Depreciation & Amortization (CF) fell to $6.8 million in Q1 2026, from $7.0 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $7.4 million in Q3 2025 to a low of $3.0 million in Q2 2022.
• A 5-year average of $5.5 million and a median of $5.8 million in 2024 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) declined 15.83% — and 2023, when it surged 81.3%.
• Tracing AGL's Depreciation & Amortization (CF) over 5 years: stood at $3.9 million in 2022, then surged by 31.74% to $5.1 million in 2023, then climbed by 26.17% to $6.5 million in 2024, then grew by 7.31% to $7.0 million in 2025, then slipped by 2.61% to $6.8 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $6.8 million (Q1 2026), $7.0 million (Q4 2025), and $7.4 million (Q3 2025), per Business Quant data.